Published in Hum Genet on September 05, 2013
Novel methylation markers of the dysexecutive-psychiatric phenotype in FMR1 premutation women. Neurology (2015) 1.45
Molecular Inconsistencies in a Fragile X Male with Early Onset Ataxia. Genes (Basel) (2016) 1.38
A pathophysiological view of the long non-coding RNA world. Oncotarget (2014) 1.36
The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease. Philos Trans R Soc Lond B Biol Sci (2014) 1.01
Fragile X-associated tremor/ataxia syndrome. Ann N Y Acad Sci (2015) 0.98
Long non-coding RNAs in neurodevelopmental disorders. Front Mol Neurosci (2013) 0.95
Natural antisense transcripts. Hum Mol Genet (2014) 0.94
RNA-protein interactions in unstable microsatellite diseases. Brain Res (2014) 0.89
Long Noncoding RNA-Directed Epigenetic Regulation of Gene Expression Is Associated With Anxiety-like Behavior in Mice. Biol Psychiatry (2015) 0.86
Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome. PLoS One (2016) 0.82
Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders. Front Genet (2014) 0.82
Short stories on zebrafish long noncoding RNAs. Zebrafish (2014) 0.81
The multiple molecular facets of fragile X-associated tremor/ataxia syndrome. J Neurodev Disord (2014) 0.80
Trinucleotide expansion in disease: why is there a length threshold? Curr Opin Genet Dev (2014) 0.79
Genome-wide differential expression of synaptic long noncoding RNAs in autism spectrum disorder. Transl Psychiatry (2015) 0.79
Changes in expression of the long non-coding RNA FMR4 associate with altered gene expression during differentiation of human neural precursor cells. Front Genet (2015) 0.78
Human pluripotent stem cell models of Fragile X syndrome. Mol Cell Neurosci (2015) 0.77
Long noncoding RNAs in psychiatric disorders. Psychiatr Genet (2016) 0.76
β-glucuronidase mRNA levels are correlated with gait and working memory in premutation females: understanding the role of FMR1 premutation alleles. Sci Rep (2016) 0.76
Epigenetics studies of fetal alcohol spectrum disorder: where are we now? Epigenomics (2017) 0.75
Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases. Yale J Biol Med (2017) 0.75
Brain structure and intragenic DNA methylation are correlated, and predict executive dysfunction in fragile X premutation females. Transl Psychiatry (2016) 0.75
Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome. Genes (Basel) (2016) 0.75
Cocaine alters Homer1 natural antisense transcript in the nucleus accumbens. Mol Cell Neurosci (2017) 0.75
Noncoding RNAs in neurodegeneration. Nat Rev Neurosci (2017) 0.75
Landscape of transcription in human cells. Nature (2012) 20.18
Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science (2005) 16.82
CDART: protein homology by domain architecture. Genome Res (2002) 12.95
Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res (2009) 10.08
Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet (2000) 6.73
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology (2001) 6.55
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature (2007) 5.57
Expandable DNA repeats and human disease. Nature (2007) 5.50
Epigenetic regulation by long noncoding RNAs. Science (2012) 4.74
Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol (2009) 4.48
Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell (1994) 4.43
DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet (1992) 4.22
Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell (2005) 4.07
Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A (1997) 4.03
Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc Natl Acad Sci U S A (2007) 3.99
Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron (2010) 3.96
Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet (2006) 3.87
Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet (2001) 3.82
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res (2002) 3.78
A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci (2002) 3.54
Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex (2000) 3.43
Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol (2010) 3.09
Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet (1991) 2.70
Long noncoding RNAs are rarely translated in two human cell lines. Genome Res (2012) 2.64
Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet (1999) 2.59
The functional genomics of noncoding RNA. Science (2005) 2.33
Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience (2001) 2.31
Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet (1999) 2.26
An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet (2007) 2.25
The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications. Proc Natl Acad Sci U S A (2006) 2.00
Advances in understanding the molecular basis of FXTAS. Hum Mol Genet (2010) 1.83
Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes Brain Behav (2005) 1.77
Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of fmr1 protein isoforms. Hum Mol Genet (1996) 1.74
Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J Biol Chem (1998) 1.63
Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet (2002) 1.59
A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One (2008) 1.57
Long-term potentiation in the hippocampus of fragile X knockout mice. Am J Med Genet (1996) 1.45
High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet (1993) 1.42
Perspectives of Long Non-Coding RNAs in Cancer Diagnostics. Front Genet (2012) 1.41
High-throughput verification of transcriptional starting sites by Deep-RACE. Biotechniques (2009) 1.16
The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum Mol Genet (2010) 1.04
Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol (2012) 1.04
Promoter-associated long noncoding RNAs repress transcription through a RNA binding protein TLS. Adv Exp Med Biol (2011) 0.90
Learning and memory in the FMR1 knockout mouse. Am J Med Genet (1999) 0.88
Promoter-associated RNAs and promoter-targeted RNAs. Cell Mol Life Sci (2012) 0.88
RNA-mediated pathogenesis in fragile X-associated disorders. Neurosci Lett (2009) 0.87
Promoter-associated noncoding RNA from the CCND1 promoter. Methods Mol Biol (2012) 0.83
Alternative splicing of the FMR1 gene in human fetal brain neurons. Am J Med Genet (1996) 0.82
Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet (2006) 17.19
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet (2009) 6.02
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A (2007) 4.69
Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol (2009) 4.48
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 4.20
Complex Loci in human and mouse genomes. PLoS Genet (2006) 3.74
The reality of pervasive transcription. PLoS Biol (2011) 3.41
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol (2012) 3.07
RNAdb--a comprehensive mammalian noncoding RNA database. Nucleic Acids Res (2005) 2.84
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res (2005) 2.27
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res (2005) 2.20
Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol (2010) 2.08
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00
Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics (2005) 1.89
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J (2005) 1.85
A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol (2008) 1.80
Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. Neurology (2013) 1.78
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med (2013) 1.74
Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridization. Hum Mutat (2007) 1.66
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med (2010) 1.64
Improved and automated prediction of effective siRNA. Biochem Biophys Res Commun (2004) 1.58
A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One (2008) 1.57
Comparison of three targeted enrichment strategies on the SOLiD sequencing platform. PLoS One (2011) 1.55
MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A (2012) 1.49
Pseudo-messenger RNA: phantoms of the transcriptome. PLoS Genet (2006) 1.46
Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet (2012) 1.46
Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes (2004) 1.41
MicroRNA dysregulation in psychiatric disease. Brain Res (2010) 1.34
Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Res (2006) 1.27
Noncoding RNAs: couplers of analog and digital information in nervous system function? Trends Neurosci (2007) 1.27
Intronic RNAs constitute the major fraction of the non-coding RNA in mammalian cells. BMC Genomics (2012) 1.26
RNA interference is not involved in natural antisense mediated regulation of gene expression in mammals. Genome Biol (2006) 1.21
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J (2007) 1.19
Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes. Genomics (2005) 1.18
microRNAs in CNS disorders. Neuromolecular Med (2009) 1.17
Analysis of siRNA specificity on targets with double-nucleotide mismatches. Nucleic Acids Res (2008) 1.14
Validating siRNA using a reporter made from synthetic DNA oligonucleotides. Biochem Biophys Res Commun (2004) 1.14
Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO Mol Med (2010) 1.12
NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci U S A (2002) 1.10
Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation (2003) 1.10
The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function. BMC Genomics (2007) 1.10
Personalized medicine in psychiatry: problems and promises. BMC Med (2013) 1.09
Activity-induced and developmental downregulation of the Nogo receptor. Cell Tissue Res (2003) 1.07
Kinetics of senescence-associated changes of gene expression in an epithelial, temperature-sensitive SV40 large T antigen model. Cancer Res (2004) 1.07
Identification of functional SNPs in the 5-prime flanking sequences of human genes. BMC Genomics (2005) 1.07
Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs. Biochem Biophys Res Commun (2003) 1.06
A new approach to genome mapping and sequencing: slalom libraries. Nucleic Acids Res (2002) 1.05
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res (2004) 1.04
Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol (2012) 1.04
The expression signature of in vitro senescence resembles mouse but not human aging. Genome Biol (2005) 1.03
Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood (2013) 1.03
Genotype-phenotype analysis of 4q deletion syndrome: proposal of a critical region. Am J Med Genet A (2012) 1.02
Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening. Mol Pharmacol (2009) 0.98
Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease. Neurosci Lett (2009) 0.96
hUNC93B1: a novel human gene representing a new gene family and encoding an unc-93-like protein. Gene (2002) 0.96
Epigenetic mechanisms of gene regulation during mammalian spermatogenesis. Epigenetics (2008) 0.95
RNA Interference with chemically modified siRNA. Curr Top Med Chem (2006) 0.93
Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept (2005) 0.93
No induction of anti-viral responses in human cell lines HeLa and MCF-7 when transfecting with siRNA or siLNA. Biochem Biophys Res Commun (2006) 0.93
Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication. FEBS Lett (2004) 0.92
GeneLynx mouse: integrated portal to the mouse genome. Genome Res (2003) 0.92
NotI flanking sequences: a tool for gene discovery and verification of the human genome. Nucleic Acids Res (2002) 0.92
Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence. Addict Biol (2008) 0.91
A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcohol Clin Exp Res (2005) 0.91
NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations. Alcohol Clin Exp Res (2003) 0.90
Functional comparison of single- and double-stranded siRNAs in mammalian cells. Biochem Biophys Res Commun (2004) 0.90
mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides. Nucleic Acids Res (2003) 0.90
Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis. Int J Alzheimers Dis (2011) 0.90
The Emerging Role of Non-Coding RNAs in Drug Addiction. Front Genet (2012) 0.89
The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease. Curr Alzheimer Res (2016) 0.89
Frequent detection of parental consanguinity in children with developmental disorders by a combined CGH and SNP microarray. Mol Cytogenet (2013) 0.89
A universal plasmid library encoding all permutations of small interfering RNA. Proc Natl Acad Sci U S A (2005) 0.89
Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin. Hum Genet (2005) 0.89
Genetics of neurological disorders. Expert Rev Mol Diagn (2004) 0.88
RNAi screen indicates widespread biological function for human natural antisense transcripts. PLoS One (2010) 0.86
Gene characterization index: assessing the depth of gene annotation. PLoS One (2008) 0.86
Mitochondrial dynamics regulate growth cone motility, guidance, and neurite growth rate in perinatal retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci (2012) 0.86
Role of Sirtuin 1 in metabolic regulation. Drug Discov Today (2010) 0.85
Epigenetic pathways and glioblastoma treatment. Epigenetics (2013) 0.85
Characterization of RNA interference in rat PC12 cells: requirement of GERp95. Biochem Biophys Res Commun (2004) 0.85
Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties. Regul Pept (2003) 0.84
Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases. J Community Genet (2014) 0.84
Adult neurogenesis: a potential tool for early diagnosis in Alzheimer's disease? J Alzheimers Dis (2010) 0.83
Focusing on RISC assembly in mammalian cells. Biochem Biophys Res Commun (2008) 0.83
Nonsynonymous SNPs: validation characteristics, derived allele frequency patterns, and suggestive evidence for natural selection. Hum Mutat (2006) 0.82
Navigating genomic maps of cancer cells. Nat Biotechnol (2010) 0.82
Next-generation sequencing of mitochondrial targeted AAV transfer of human ND4 in mice. Mol Vis (2013) 0.81
Transcriptional repression of ER through hMAPK dependent histone deacetylation by class I HDACs. Breast Cancer Res Treat (2014) 0.80
Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats. Eur Neuropsychopharmacol (2003) 0.79
Functional interactions between delta- and mu-opioid receptors in rat thermoregulation. Eur J Pharmacol (2003) 0.79
Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model. J Peripher Nerv Syst (2014) 0.78
Quantitative codon optimisation of DNA libraries encoding sub-random peptides: design and characterisation of a novel library encoding transmembrane domain peptides. Nucleic Acids Res (2002) 0.78
Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists. Bioorg Med Chem Lett (2012) 0.77
Vector-based siRNA delivery strategies for high-throughput screening of novel target genes. J RNAi Gene Silencing (2005) 0.76
Analysis of 5-hydroxytryptamine 2c receptor gene promoter variants as alcohol-dependence risk factors. Alcohol Alcohol (2004) 0.76
Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes. Orphanet J Rare Dis (2014) 0.76
Oligonucleotides for upregulating gene expression. Pharm Pat Anal (2013) 0.76